Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries
- PMID: 33546810
- PMCID: PMC9756569
- DOI: 10.1016/j.vaccine.2021.01.015
Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries
Keywords: COVID-19; SARS-CoV-2; The World Health Organization; Vaccine development.
Conflict of interest statement
Declaration of Competing Interest The author declares that he has no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment in
-
Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.Vaccine. 2021 Feb 12;39(7):1028-1029. doi: 10.1016/j.vaccine.2021.01.020. Vaccine. 2021. PMID: 33546811 Free PMC article. No abstract available.
Comment on
-
So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development.Vaccine. 2020 Sep 22;38(41):6381-6387. doi: 10.1016/j.vaccine.2020.08.017. Epub 2020 Aug 11. Vaccine. 2020. PMID: 32826103 Free PMC article. Review.
References
-
- The World Health Organization. COVAX: Working for global equitable access to COVID-19 vaccines. https://www.who.int/initiatives/act-accelerator/covax (accessed August 25, 2020).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
